Clinical Trial Update: Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for sarizotan in Rett syndrome with respiratory symptoms has terminated; results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• Sarizotan (sarizotan)

Snippet

Sponsor: Newron Pharmaceuticals SPA | Conditions: Rett Syndrome | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-12-21